• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项全国性心房颤动前瞻性队列研究中,缺血性卒中在节律控制与心率控制策略中的比较发生率。

Comparative occurrence of ischemic stroke with the rhythm versus rate control strategy in a national prospective cohort of atrial fibrillation.

作者信息

Kim Jae Guk, Lee Young Soo, Kang Ki-Woon, Choi Eue-Keun, Cha Myung-Jin, Lee Jung-Myung, Kim Jin-Bae, Park Junbeom, Park Jin-Kyu, Kim Tae-Hoon, Uhm Jae-Sun, Shim Jaemin, Kim Jun, Park HyungWook, Kim Changsoo, Joung Boyoung

机构信息

Department of Neurology, Eulji University Hospital, Daejeon, Korea.

Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.

出版信息

Korean J Intern Med. 2021 Jan;36(1):114-123. doi: 10.3904/kjim.2019.063. Epub 2019 Oct 14.

DOI:10.3904/kjim.2019.063
PMID:31597907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7820664/
Abstract

BACKGROUND/AIMS: Comparative occurrence of ischemic stroke for rhythm versus rate control strategy in patients with non-valvular atrial fibrillation (NVAF) is still inconclusive. The purpose of this study was to investigate whether the rhythm control strategy is associated with a lower risk of ischemic stroke compared to the rate control strategy in NVAF patients.

METHODS

The CODE-AF registry prospectively enrolled 6,280 consecutive patients who were treated for NVAF at 10 tertiary referral centers in South Korea. Of these, 2,513 NVAF patients (age, 67 ± 10 years; male, 61.8%) were clinically followed up for over 1-year and divided into rate and rhythm control groups.

RESULTS

Those treated with the rhythm control strategy were younger and had less proportions of underlying disease compared to those treated with the rate control strategy. After the propensity matching analysis, those treated with the rhythm control strategy had similar baseline characteristics including the CHA2DS2-VASC score compared to those treated with the rate control strategy. The rate of oral anticoagulation, all bleeding, and hospitalization were also similarly between the two groups. The incidence rate of ischemic stroke in the rhythm control group was significantly lower than in the rate control group (0.7 vs. 6.9 per 1,000 person-years, p = 0.011).

CONCLUSION

The rhythm control strategy demonstrated a beneficial effect to lower the risk of ischemic stroke during a 1-year follow-up compared to the rate control strategy.

摘要

背景/目的:在非瓣膜性心房颤动(NVAF)患者中,节律控制与心率控制策略相比,缺血性卒中的相对发生率仍无定论。本研究的目的是调查在NVAF患者中,与心率控制策略相比,节律控制策略是否与较低的缺血性卒中风险相关。

方法

CODE-AF注册研究前瞻性纳入了韩国10家三级转诊中心连续治疗的6280例NVAF患者。其中,2513例NVAF患者(年龄67±10岁;男性占61.8%)进行了超过1年的临床随访,并分为心率控制组和节律控制组。

结果

与接受心率控制策略治疗的患者相比,接受节律控制策略治疗的患者更年轻,基础疾病比例更低。倾向匹配分析后,与接受心率控制策略治疗的患者相比,接受节律控制策略治疗的患者具有相似的基线特征,包括CHA2DS2-VASC评分。两组的口服抗凝率、所有出血率和住院率也相似。节律控制组的缺血性卒中发生率显著低于心率控制组(每1000人年0.7例 vs. 6.9例,p = 0.011)。

结论

与心率控制策略相比,节律控制策略在1年随访期间显示出降低缺血性卒中风险的有益效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0900/7820664/a3275fd2ffb7/kjim-2019-063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0900/7820664/a3275fd2ffb7/kjim-2019-063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0900/7820664/a3275fd2ffb7/kjim-2019-063f1.jpg

相似文献

1
Comparative occurrence of ischemic stroke with the rhythm versus rate control strategy in a national prospective cohort of atrial fibrillation.在一项全国性心房颤动前瞻性队列研究中,缺血性卒中在节律控制与心率控制策略中的比较发生率。
Korean J Intern Med. 2021 Jan;36(1):114-123. doi: 10.3904/kjim.2019.063. Epub 2019 Oct 14.
2
Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.房颤相关性缺血性卒中患者,既往抗凝治疗者,复发卒中风险更高。
Stroke. 2020 Apr;51(4):1150-1157. doi: 10.1161/STROKEAHA.119.027275. Epub 2020 Feb 26.
3
Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中的病因
Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.
4
Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.HIV 感染者合并心房颤动的流行情况及其相关卒中风险:一项全国性队列研究。
Circ J. 2019 Nov 25;83(12):2547-2554. doi: 10.1253/circj.CJ-19-0527. Epub 2019 Oct 17.
5
Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.利伐沙班治疗非瓣膜性心房颤动合并缺血性卒中和短暂性脑缺血发作史患者的真实世界结局。
Cerebrovasc Dis. 2019;48(1-2):53-60. doi: 10.1159/000502883. Epub 2019 Oct 2.
6
Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHADS-VASc scores.在考虑低 CHADS-VASc 评分的房颤患者抗凝策略时,左心耳形态和血流动力学的附加价值。
Heart Rhythm. 2017 Sep;14(9):1297-1301. doi: 10.1016/j.hrthm.2017.05.034. Epub 2017 May 27.
7
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.急性缺血性卒中合并心房颤动患者的早期复发与脑出血:抗凝治疗及其时机的影响:RAF研究
Stroke. 2015 Aug;46(8):2175-82. doi: 10.1161/STROKEAHA.115.008891. Epub 2015 Jun 30.
8
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis.CHA2DS2-VASc 评分在预测伴有或不伴有心房颤动的缺血性卒中患者中的作用:系统评价和荟萃分析。
Eur J Prev Cardiol. 2022 Mar 30;29(4):625-631. doi: 10.1093/eurjpc/zwab018.
9
Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.CHA2DS2-VASc 评分的动态变化与亚洲房颤患者缺血性卒中风险:一项全国性队列研究。
Thromb Haemost. 2018 Jul;118(7):1296-1304. doi: 10.1055/s-0038-1651482. Epub 2018 May 3.
10
CHADS-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.用于识别真正低风险房颤卒中的CHADS-VASc评分:一项韩国全国性队列研究
Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.

引用本文的文献

1
Which Is Better? Rate Versus Rhythm Control in Atrial Fibrillation: A Systematic Review.哪种方法更好?心房颤动的心率控制与节律控制:一项系统评价。
Cureus. 2023 Dec 3;15(12):e49869. doi: 10.7759/cureus.49869. eCollection 2023 Dec.

本文引用的文献

1
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry.房颤患者的节律控制与心率控制及临床结局:ORBIT-AF注册研究结果
JACC Clin Electrophysiol. 2016 Apr;2(2):221-229. doi: 10.1016/j.jacep.2015.11.001. Epub 2015 Nov 26.
2
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.导管消融与抗心律失常药物治疗心房颤动(CABANA)试验:研究背景和设计。
Am Heart J. 2018 May;199:192-199. doi: 10.1016/j.ahj.2018.02.015. Epub 2018 Mar 7.
3
A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry.
一项关于心房颤动管理的前瞻性调查,以了解现实世界中对指南的遵循情况:心房颤动症状控制和并发症预防药物比较研究(CODE-AF)注册研究。
Korean Circ J. 2017 Nov;47(6):877-887. doi: 10.4070/kcj.2017.0146. Epub 2017 Oct 17.
4
The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis.节律控制策略与心率控制策略治疗心房颤动和心房扑动的效果:一项系统评价、荟萃分析及试验序贯分析
PLoS One. 2017 Oct 26;12(10):e0186856. doi: 10.1371/journal.pone.0186856. eCollection 2017.
5
Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis.心房颤动导管消融与降低中风和死亡率风险相关:一项倾向评分匹配分析。
Heart Rhythm. 2017 May;14(5):635-642. doi: 10.1016/j.hrthm.2017.02.001. Epub 2017 Feb 9.
6
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
7
Stroke prevention in atrial fibrillation.心房颤动的卒中预防。
Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0.
8
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.心脏手术后房颤的心率控制与节律控制
N Engl J Med. 2016 May 19;374(20):1911-21. doi: 10.1056/NEJMoa1602002. Epub 2016 Apr 4.
9
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.非手术患者心房颤动和静脉血栓栓塞性疾病抗凝剂研究中临床相关非大出血的定义:国际血栓与止血学会科学与标准化委员会的沟通
J Thromb Haemost. 2015 Nov;13(11):2119-26. doi: 10.1111/jth.13140.
10
Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke.非瓣膜性心房颤动患者伴缺血性卒中和短暂性脑缺血发作的抗栓治疗:韩国卒中临床实践指南执行摘要。
J Stroke. 2015 May;17(2):210-5. doi: 10.5853/jos.2015.17.2.210. Epub 2015 May 29.